Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
Is Renewed MNC Optimism in China Sustainable amid Intensified Cost Containment a...
Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on deciphering accelerated growth of MNC China business in r... (12/3/2018)
   
Hong Kong Could Become A Hub for Genetics-Based Drugs Discovery. Just One Hitch - Would Beijing Stand in Way? (12/12/2018)
Wuxi AppTec Says US Hurdles Will Not Dim Acquisition Appetite (12/5/2018)
BeiGene Mounts Its Assault On The Ibrutinib Hegemony (12/5/2018)
US Biotech Firms Made China's Gene-Edited Babies Possible (12/4/2018)
U.S.-China Trade Tensions Threaten Biotech Cash Surge (12/4/2018)
J&J to Build Blood-Cancer Push With Controversial China Biotech (12/4/2018)
Is Renewed MNC Optimism in China Sustainable amid Intensified Cost Containment and Slowing Economy? (12/3/2018)
Who Are the Investors Supporting He Jiankui, the Chinese Scientist behind the Gene-edited Babies? (11/29/2018)
WSJ: Drugmakers Gain More Access to China, But at a Price (11/27/2018)
Gene-Edited Babies: China Wants To Be The World Leader, But At What Cost? (11/26/2018)
China Pins Its Hopes on Beating US in Race for Bio-Intelligence Supremacy (11/26/2018)
Trump Administration Accuses China of Unfairly Using Venture Capital to Acquire American Biotech (11/22/2018)
How China Will Handle Its Trade War With the United States in 2019 (11/15/2018)
CFIUS Broadens Coverage of Cross-Border Biotech Transactions (11/13/2018)
China's Crackdown on Genetics Breaches Could Deter Data Sharing (11/13/2018)
Recent Official and Executive Moves  (12/14/2018)
NHC Set to Launch National Adjuvant Drug...  (12/14/2018)
Promising Phase 3 Results For Green Vall...  (12/13/2018)
State Council Passes Final Draft of 4th ...  (12/13/2018)
JW Therapeutics Opens R&D Center in ...  (12/13/2018)
Innovent Announces Positive Outcome of T...  (12/13/2018) (free)
WuXi AppTec Failed to Shine on HKEx Debu...  (12/13/2018) (free)
Zai Lab Announces Acceptance of Its NDA ...  (12/12/2018)
IntelGenx Partners with Gensco Pharma to...  (12/12/2018)
Actelion Granted Chinese Approval for PA...  (12/12/2018)
Luye Pharma Files IND for CNS Drug LY030...  (12/12/2018)
USFDA Warns Zhejiang Huahai for Failure ...  (12/11/2018)
Aurobindo Subsidiary and Luoxin Agree to...  (12/11/2018)
Junshi Biosciences Aims to Raise $414M i...  (12/11/2018)
Lonza to Establish Strategic Biomanufact...  (12/11/2018)
Top 25 Global Pharmaceutical Companies by Market Cap 201...
CANbridge Receives IND Approval to Commence CAN008 Phase...
Global Contract Pharmaceutical Manufacturing Market to R...
White House Task Force Echoes Pharma Proposals
Pharma Industry Reputation Rebounds Somewhat in 2016
NH Reports on Chinese OTC Sleep Aids Market in MAT Q3/2018
NH: Chinese OTC Market Growth Steady in MAT Q3 2018, Outpacing ...
SMEI President Predicts Continued Chinese Pharma Growth in 2019...
China Faces Flu Vaccines Shortage amid Rising Demand and Manufa...
IQVIA: The Chinese Pharmaceutical Market to Grow at 5.5% CAGR b...
JW Therapeutics Opens R&D Center in Shanghai
WuXi AppTec Failed to Shine on HKEx Debut
IntelGenx Partners with Gensco Pharma to Market RIZAPORT in ...
Actelion Granted Chinese Approval for PAH Drug Uptravi (Sele...
Aurobindo Subsidiary and Luoxin Agree to Form Chinese JV
SAMR Fines Three Violators as It Steps Up Anti-monopoly ...
NMPA Issues Announcement for One-time Import of Referenc...
MOFCOM Solicits Comments on Draft Guidelines for Nationa...
National Pharmacopoeia Commission Solicits Comments on G...
CDE Solicits Comments on Guideline for Clinical Research...
State Council Passes Final Draft of 4th Amendment of Chinese...
State Council Approves Patent Amendment Draft and Policies t...
China Introduces A Range of New Punishments for IP Violation...
NMPA Signs MOU with MPP after Joining WHO’s COPP
President Xi Pledges to Protect IP and Boost Import at 1st I...
USFDA Warns Zhejiang Huahai for Failure to Detect Valsar...
Chinese Heparin Maker Yibin Lihao Bio Banned by EMA over...
Huahai Pharma Faces Lawsuits on Cancer-Causing Valsartan...
Zheijiang Huahai Placed under Increased Supervision
EU, U.S. and Canada Investigating Second Impurity in Hua...
Promising Phase 3 Results For Green Valley’s Alzheimer’...
Innovent Announces Positive Outcome of Two Clinical Stud...
Zai Lab Announces Acceptance of Its NDA for ZEJULA (Nira...
Luye Pharma Files IND for CNS Drug LY03003 in Japan
Innovent Gains US FDA Approval to Initiate Clinical Tria...
NHC Set to Launch National Adjuvant Drug List Soon
National Centralized Drug Purchase Trial Upsets Pharma I...
NHC and SMIA Reach Consensus about Use of HTA for BMI Re...
NHC and SATCM Issue New Pharmacy Service Policy, Banning...
NHC: HIV/AIDS Rate at Low Level in China
Recent Official and Executive Moves
Recent Executive Moves
Recent Official and Executive Moves
Recent Executive Moves
Recent Executive Moves
China to Launch New Tech Bourse in Shanghai
Upcoming Event: 2nd International Conference on Vaccines...
Upcoming Event: 31st Annual Cardiologists Conference
Upcoming Event: Phar-East 2019
Upcoming Event: Health Insurance Innovation Congress Asi...
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Publishes the China Phar...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links